(Q38110203)

29 August 2017

title

Intermediate hepatocellular carcinoma: current treatments and future perspectives (English)

1 reference

29 August 2017

main subject

hepatocellular carcinoma

1 reference

J-F Dufour

1

1 reference

29 August 2017

I Bargellini

2

1 reference

29 August 2017

N De Maria

3

1 reference

29 August 2017

P De Simone

4

1 reference

29 August 2017

I Goulis

5

1 reference

29 August 2017

R T Marinho

6

1 reference

29 August 2017

publication date

1 April 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

24 Suppl 2

1 reference

29 August 2017

page(s)

ii24-9

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Therapeutic options for intermediate-advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT054

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT054

1 reference

29 August 2017

1 reference